Live feed
Filing
SC 13G
SC 13G0000930413-24-002250·Biodexa Pharmaceuticals PLC/ADR
Schedule 13G ownership disclosure
BIODEXA PHARMACEUTICALS PLC
Security class unavailable · CUSIP: 59564R708
Event date: 2024-07-19
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 327,660
- Percent of class
- 7.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000930413-24-002250
- Form type
- SC 13G
- Filer
- Biodexa Pharmaceuticals PLC/ADR
- CIK
- CIK 1832898
- Filed
- Aug 05, 2024
- Reporting period
- Jul 19, 2024
- Description
- Schedule 13G beneficial ownership